A HUMAN LABORATORY STUDY OF MIFEPRISTONE AS A NOVEL TREATMENT FOR ALCOHOL USE DISORDER

被引:0
|
作者
Mason, Barbara J. [1 ]
机构
[1] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
R91
引用
收藏
页码:224 / 224
页数:1
相关论文
共 50 条
  • [11] Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models
    Yardley, Megan M.
    Ray, Lara A.
    ADDICTION BIOLOGY, 2017, 22 (03) : 581 - 615
  • [12] A Human Laboratory Study on the Effects of a Novel Ghrelin Receptor Inverse Agonist Competitive Antagonist on Alcohol and Food-Related Behaviors in Individuals With Alcohol Use Disorder
    Faulkner, Monica
    Farokhnia, Mehdi
    Farinelli, Lisa
    Deschaine, Sara
    Browning, Brittney
    Akhlaghi, Fatemeh
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 311 - 312
  • [13] A Human Laboratory Study on the Effects of a Novel Ghrelin Receptor Inverse Agonist Competitive Antagonist on Alcohol and Food-Related Behaviors in Individuals With Alcohol Use Disorder
    Faulkner, Monica
    Farokhnia, Mehdi
    Farinelli, Lisa
    Deschaine, Sara
    Browning, Brittney
    Akhlaghi, Fatemeh
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 311 - 312
  • [14] Exercise as treatment for alcohol use disorder: A qualitative study
    Gunillasdotter, Victoria
    Andreasson, Sven
    Hallgren, Mats
    Jirwe, Maria
    DRUG AND ALCOHOL REVIEW, 2022, 41 (07) : 1642 - 1652
  • [15] A Novel Interactive Video Module for Providers on Treating Alcohol Use Disorder: The Treatment Education for Alcohol Misuse (TEAM) Study
    Twohig, Patrick
    Benton-Slocum, Zachary
    Balasanova, Alena A.
    Khoury, Nathalie
    Ashford, Allison
    Scholten, Kyle
    Warner, Josh
    Gallagher, John
    Peeraphatdit, Thoetchai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1146 - S1146
  • [16] A Human Laboratory Study of the mGluR5 Modulator Get 73 on Alcohol Craving, Pharmacokinetics and Pharmacodynamics in Individuals With Alcohol Use Disorder
    Swift, Robert
    Haass-Koffler, Carolina
    Leggio, Lorenzo
    Cacciaglia, Roberto
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S456 - S456
  • [17] The use of pharmacotherapy in the treatment of alcohol use disorder
    Allen, Kathryn
    Maharaj, Tobias
    Ryan, John
    JOURNAL OF HEPATOLOGY, 2022, 77 : S138 - S138
  • [18] EFFECTS OF VARENICLINE IN HUMAN LABORATORY MODELS FOR SCREENING OFPHARMACOTHERAPEUTICS FOR ALCOHOL USE DISORDER.
    Vatsalya, V.
    Gowin, J. L.
    Schwandt, M. L.
    Momenan, R.
    Heilig, M.
    Bardett, S. E.
    Ramchandani, V. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S21 - S21
  • [19] Treatment Resistant Alcohol Use Disorder
    Patterson Silver Wolf, David A.
    Dulmus, Catherine N.
    Wilding, Gregory E.
    Yu, Jihnhee
    Barczykowski, Amy L.
    Shi, Tiange
    Diebold, Josal R.
    Harvey, Steven J.
    Tomasello, Nicole M.
    Linn, Braden K.
    ALCOHOLISM TREATMENT QUARTERLY, 2022, 40 (02) : 205 - 216
  • [20] Outpatient treatment of alcohol use disorder
    Molavi, Armon
    Guruge, Sulara
    Kelly, Peter
    BRITISH COLUMBIA MEDICAL JOURNAL, 2020, 62 (08): : 272 - 276